Cardinal Health, Inc. (NYSE:CAH) Given Consensus Rating of “Moderate Buy” by Analysts

Cardinal Health, Inc. (NYSE:CAH) has been assigned an average recommendation of “Moderate Buy” from the sixteen research firms that are presently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. The average 1-year price target among brokers that have covered the stock in the last year is $212.60.

Several brokerages have recently commented on CAH. Robert W. Baird set a $232.00 price objective on Cardinal Health in a report on Friday, October 31st. Argus boosted their price target on shares of Cardinal Health from $189.00 to $211.00 and gave the stock a “buy” rating in a research note on Tuesday, November 4th. Mizuho raised their price objective on shares of Cardinal Health from $170.00 to $210.00 and gave the company an “outperform” rating in a research report on Monday, November 3rd. Wells Fargo & Company lifted their price objective on shares of Cardinal Health from $185.00 to $221.00 and gave the stock an “overweight” rating in a report on Wednesday, November 5th. Finally, Weiss Ratings reissued a “buy (b)” rating on shares of Cardinal Health in a research note on Wednesday, October 8th.

Cardinal Health Stock Performance

Cardinal Health stock opened at $201.06 on Wednesday. Cardinal Health has a fifty-two week low of $119.25 and a fifty-two week high of $214.93. The stock has a market cap of $47.77 billion, a P/E ratio of 30.33, a PEG ratio of 1.46 and a beta of 0.65. The firm’s fifty day moving average price is $204.05 and its 200-day moving average price is $173.23.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, October 30th. The company reported $2.55 EPS for the quarter, topping the consensus estimate of $2.22 by $0.33. The business had revenue of $64.01 billion during the quarter, compared to analysts’ expectations of $59.41 billion. Cardinal Health had a negative return on equity of 84.37% and a net margin of 0.68%.The firm’s revenue was up 22.4% on a year-over-year basis. During the same period in the previous year, the business earned $1.88 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. Sell-side analysts predict that Cardinal Health will post 7.95 earnings per share for the current year.

Cardinal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd will be given a dividend of $0.5107 per share. The ex-dividend date is Friday, January 2nd. This represents a $2.04 annualized dividend and a dividend yield of 1.0%. Cardinal Health’s dividend payout ratio is 30.77%.

Institutional Trading of Cardinal Health

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Counterpoint Mutual Funds LLC bought a new stake in shares of Cardinal Health in the second quarter worth $1,911,000. Strs Ohio purchased a new position in Cardinal Health in the first quarter worth about $2,652,000. Baird Financial Group Inc. grew its stake in shares of Cardinal Health by 107.2% during the 2nd quarter. Baird Financial Group Inc. now owns 99,393 shares of the company’s stock valued at $16,698,000 after purchasing an additional 51,416 shares during the period. Nomura Holdings Inc. grew its stake in shares of Cardinal Health by 568.0% during the 2nd quarter. Nomura Holdings Inc. now owns 85,293 shares of the company’s stock valued at $14,329,000 after purchasing an additional 72,525 shares during the period. Finally, Voya Investment Management LLC increased its position in shares of Cardinal Health by 298.3% during the 3rd quarter. Voya Investment Management LLC now owns 821,723 shares of the company’s stock valued at $128,978,000 after purchasing an additional 615,398 shares during the last quarter. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.